With the fate of the BIOSECURE Act currently in limbo, WuXi AppTec is looking on the brighter side for 2025. | With the fate ...
China health care companies received a significant reprieve in terms of geopolitical risks when the US Senate declined to ...
A year after the Biosecure Act was introduced, WuXi AppTec’s US revenue growth continued to drop significantly, and the ...
The signs of WuXi AppTec's performance rebound were evident last quarter, with its net profit soaring 91 percent to CNY2.9 ...
WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and life sciences industry ...
WuXi has disputed an early WBJ report saying construction at the Worcester site has stopped, although the company declined to ...
Successfully tested, the Chinese nuclear battery can change the energy industry, boosting advances on the Internet of Things ...
What if China decided to sever American access to the drug ingredients your sick kid depends on? But America’s losing ...
NANJING, March 12 (Xinhua) -- In the latest step to clean energy technology, a Chinese company said that it has developed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback